Download PDF
Thromb Haemost 1978; 39(03): 743-750
DOI: 10.1055/s-0038-1646751
Original Article
Schattauer GmbH Stuttgart

Plasminogen Activator Levels in Plasma and Urine during Exercise and Oral Contraceptive Use

Anne M Hedlin
The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada
,
Susan Milojevic
The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada
,
Andrew Korey
The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada
› Author Affiliations
Further Information

Publication History

Received 23 September 1977

Accepted 26 November 1977

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The effect of Demulen (ethinyl estradiol 0.05 mg and ethynodiol diacetate 1 mg) and exercise on the level of plasminogen activators was studied in 25 women (12 controls and 13 contraceptive users).Plasma plasminogen activator level was increased by the use of the oral contraceptive and further increased by exercise. Urine plasminogen activator level was unchanged by the use of Demulen but, in both groups of subjects, was decreased by exercise.

 

  • References

  • 1 Abiko N, Von Kaulla K. 1971; Dissimilarity of human vascular plasminogen activator and human urokinase. Journal of Laboratory and Clinical Medicine 78: 354
    PubMedGoogle Scholar
  • 2 Amris CJ, Starup J. 1967; The coagulation mechanism in oral contraception. Acta obstetricia et gynecologica Scandinavica 46: 78
    CrossrefPubMedGoogle Scholar
  • 3 Asbeck F, Lechler E, Van De Loo J. 1971; Das Verhalten des fibrinolytischen Systems unter Oestrogen-Gestagen-Kombination. Thrombosis et Diathesis Haemorrhagica Suppl. 48-50: 133
    PubMedGoogle Scholar
  • 4 Asbeck F, Bolte A, Henning HD, Hordemann K, Latz R, Lechler E, Van De Loo J. 1972; The mechanism of intravascular activation of the fibrinolytic system during oral contraception. Haemostasis 1: 108
    PubMedGoogle Scholar
  • 5 Astedt B. 1971; Low fibrinolytic activity of the veins during treatment with ethinyloestradiol. Acta obstetricia et gynecologica Scandinavica 50: 279
    CrossrefPubMedGoogle Scholar
  • 6 Bick RL, Thompson WB. 1972; Fibrinolytic activity. Obstetrics and Gynecology 39: 213
    PubMedGoogle Scholar
  • 7 Biggs R, Macfarlane RG, Pilling J. 1947; Observations on fibrinolysis. Lancet 1: 402
    PubMedGoogle Scholar
  • 8 Brakman P, Sobrero AJ, Astrup T. 1970; Effects of different systemic contraceptives on blood fibrinolysis. American Journal of Obstetrics and Gynecology 106: 187
    CrossrefPubMedGoogle Scholar
  • 9 Cohen RJ, Epstein SE, Cohen LS, Dennis LH. 1968; Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic receptor stimulation. Lancet 2: 1264
    PubMedGoogle Scholar
  • 10 Davis GL, Abilgaard CF, Bernauer EM, Britton M. 1976; Fibrinolytic and hemostatic changes during and after maximal exercise in males. Journal of Applied Physiology 40: 287
    CrossrefPubMedGoogle Scholar
  • 11 Ferguson EW, Guest MM. 1974; Exercise, physical conditioning, blood coagulation and fibrinolysis. Thrombosis et Diathesis Haemorrhagica 31: 63
    PubMedGoogle Scholar
  • 12 Hedlin AnneM. 1975; The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis. Thrombosis et Diathesis Haemorrhagica 33: 370
    PubMedGoogle Scholar
  • 13 Hedlin AM, Monkhouse FC. 1971; Changes in spontaneous fibrinolytic activity during use of oral contraceptives. Obstetrics and Gynecology 37: 225
    PubMedGoogle Scholar
  • 14 Hedner U, Nilsson IM, Isacson S. 1975; Effect of ethyloestrenol on fibrinolysis in the vessel wall. Thrombosis et Diathesis Haemorrhagica 34: 609
    PubMedGoogle Scholar
  • 15 Iatridis SG, Ferguson JH. 1963; Effects of physical exercise on blood coagulation and fibrinolyisis. Journal of Applied Physiology 18: 337
    CrossrefPubMedGoogle Scholar
  • 16 Kuchinski CS, Fletcher AP, Sherry S. 1968; Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. Journal of Clinical Investigation 47: 1238
    CrossrefPubMedGoogle Scholar
  • 17 Menon IS, Madras MB, Burke F, Dewar HA. 1967; Effect of strenuous and graded exercise on fibrinolytic activity. Lancet 1: 700
    PubMedGoogle Scholar
  • 18 Nilsson IM, Kullander S. 1967; Coagulation and fibrinolytic studies during use of gestagens. Acta obstetricia et gynecologica Scandinavica 46: 286
    CrossrefPubMedGoogle Scholar
  • 19 Painter RH, Charles AF. 1962; Characterization of a soluble plasminogen activator from kidney culture cells. American Journal of Physiology 202: 1125
    PubMedGoogle Scholar
  • 20 Rosing DR, Brakman P, Redwood DR, Goldstein RE, Beiser GD, Astrup T. 1970; Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circulation Research 27: 171
    CrossrefPubMedGoogle Scholar
  • 21 Sartwell PE. 1971; Oral contraceptives and thromboembolism: A further report. American Journal of Epidemiology 94: 192
    CrossrefPubMedGoogle Scholar
  • 22 Sawyer WD, Fletcher AP, Alkjaersig N, Sherry S. 1960; Studies on the thrombolytic activity of human plasma. Journal of Clinical Investigation 39: 426
    CrossrefPubMedGoogle Scholar
  • 23 Sherry S, Lindemyer RI, Fletcher AP, Alkjaersig N. 1959; Studies on enhanced fibrinolytic activity in man. Journal of Clinical Investigation 38: 810
    CrossrefPubMedGoogle Scholar
  • 24 Vessey MP, Doll R. 1968; Investigation of relationship between the use of oral contraceptives and thromboembolic disease. British Medical Journal 2: 199
    CrossrefPubMedGoogle Scholar
  • 25 Von Kaulla K. 1954; Urine adsorbate with fibrinolytic and thromboplastic properties. Journal of Laboratory and Clinical Medicine 44: 944
    PubMedGoogle Scholar
  • 26 Vreeken J, Boomaard J, Deggeller K. 1966; Urokinase excretion in patients with renal disease. Acta medica Scandinavica 180: 153
    PubMedGoogle Scholar